About Enhancer
| Enhancer ID: | E_01025 |
| Species: | Homo sapiens |
| Position : | chr8:129188417-129189959   |
| Year: | 2016 |
| Title: | Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | lung adenocarcinoma |
| PMID: | 26656844 |
| MONDO: | MONDO:0005061 |
| Tissue: | lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | NCI-H358 |
| CVCL ID: | CVCL_1559 |
| Cell Type: | club cell |
| Cell Ontology ID: | CL:0000158 |
| Experiment Type: | Enhancer activity assay; Chromatin profiling; Endogenous enhancer perturbation |
| High Throughput Method: | H3K27ac ChIP-seq; p300 ChIP-seq; DNase-seq |
| Low Throughput Method: | Luciferase reporter assay of constituent enhancers e1-e5; CRISPR-Cas9 endogenous deletion/editing |
About Target Gene
| Target gene : | MYC |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
9 found
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00951 | chr8:129166547-129190290 | lung | malignant cell | lung adenocarcinoma |
| E_00974 | chr8:129166547-129190290 | lung | malignant cell | lung adenocarcinoma |
| E_00975 | chr8:129166547-129190290 | lung | malignant cell | lung adenocarcinoma |
| E_02502 | chr8:129180000-129190000 | lymph node | B cell | diffuse large B-cell lymphoma |
| E_02503 | chr8:129180000-129190000 | lymph node | B cell | diffuse large B-cell lymphoma |
| E_02504 | chr8:129180000-129190000 | lymph node | B cell | diffuse large B-cell lymphoma |
| E_00949 | chr8:129188417-129189959 | lung | malignant cell | lung adenocarcinoma |
| E_00950 | chr8:129188417-129189959 | lung | malignant cell | lung adenocarcinoma |
| E_01020 | chr8:129188417-129189959 | lymph node | malignant cell | lung adenocarcinoma |
Expression of Target Genes for the Enhancer